Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Sales | 8,432 | 51,069 | 763 | 6 | 6 |
Gross Profit | 8,432 | 51,069 | 763 | 6 | 6 |
Operating Expenses | 84,657 | 114,553 | 70,397 | 58,980 | 200,379 |
Operating Income | -76,225 | -63,484 | -69,634 | -58,974 | -200,373 |
Other Income | 7,011 | -1,223 | 41,516 | -17,279 | -1,187 |
Pre-tax Income | -69,214 | -64,707 | -28,118 | -76,253 | -201,560 |
Net Income Continuous | -69,214 | -64,707 | -28,118 | -76,253 | -201,560 |
Net Income | $-69,214 | $-64,707 | $-28,118 | $-76,253 | $-201,560 |
EPS Basic Total Ops | -1.01 | -0.77 | -0.42 | -1.23 | -3.35 |
EPS Basic Continuous Ops | -1.01 | -0.77 | -0.42 | -1.23 | -3.35 |
EPS Diluted Total Ops | -1.01 | -0.77 | -0.42 | -1.23 | -3.35 |
EPS Diluted Continuous Ops | -1.01 | -0.77 | -0.42 | -1.23 | -3.35 |
EBITDA(a) | $-73,303 | $-60,897 | $-67,909 | $-57,323 | $-198,960 |